Investor Type | Firm |
Type of Fund | VC |
Industries | Mobile • Nanotechnology |
Stages | Early Stage, Seed |
Oxen9 is a prominent venture capital firm that specializes in early-stage and seed investments, operating as a crucial bridge between the seed stage and Series A funding rounds for companies with high potential. Founded in 2017 and based in Beer Sheva, Israel, they primarily invest in companies across various sectors, including food tech, agrotech, nanotech, enterprise software, mobile, and new media. Oxen9's approach is to support visionary founders both financially and strategically, providing the necessary capital bridge and in-depth expertise to scale up operations. With a focus on capital-efficient technology, proof of first revenue, high-value markets, and clear business models, they target initial investments ranging from $250,000 to $1 million, holding reserves for future funding rounds. The firm commonly exits at the next funding stage, though they may also co-invest with other leading funds in some cases. Their investment strategy is marked by a hands-on approach that allows them to maintain control and influence over business operations, emphasizing a short ROI period, usually between 6 to 48 months, with an average exit at 24 months. Oxen9's investment focus spans food tech and agrotech (primary focus), nanotechnology, enterprise software, as well as mobile and new media. They operate globally, with a presence in Australia and Brazil, in addition to their headquarters in Israel. The firm boasts a unique and practical approach, starting with a strong deal flow generated by collaborations with VCs, private equity firms, and leading angels. A thorough partnership and due diligence process evaluates all business aspects, laying the groundwork for scaling the company and leading it to market leadership. Ultimately, they prepare for a successful secondary or exit stage by inviting relevant VCs, private equity, and corporations to join and guide the transition during the handover of the company.